Literature DB >> 6876743

Roles of selenium and sulfur-containing amino acids in protection against oxygen toxicity.

H J Forman, E I Rotman, A B Fisher.   

Abstract

Tolerance and adaptation to hyperoxia have been correlated with increases in antioxidant enzymes. This study evaluated whether selenium deficiency would prevent an increase in glutathione peroxidase (GSHPX), a selenium-containing enzyme, during oxygen exposure, and, thus, inhibit adaptation. Because the Torula yeast-based diet, which was used to produce selenium deficiency, was also deficient in cysteine and methionine, the effects of these deficiencies were also evaluated. When rats were exposed to 80% oxygen for 1 week, mortality was 80% for rats deficient in both selenium and the sulfur-containing amino acids, 40% for selenium-deficient rats, 35% for cysteine- and methionine-deficient rats, and 0% for rats fed either a standard laboratory diet or a selenium, cysteine-, and methionine-supplemented Torula yeast diet. However, only one of the six surviving rats with low selenium and none of the rats from any other dietary group died during a subsequent 96 hours of 98% oxygen, indicating adaptation to hyperoxia (LD50 for unadapted rats is 72 hours.) GSHPX activity (per gram of dry weight) was decreased 85% in lungs from unexposed rats fed the low selenium diets. After oxygen exposure, lung GSHPX activity was elevated in all dietary groups. Rats fed the high selenium diets had a 47% increase in enzyme activity, whereas rats with high selenium had a 214% increase. Although hyperoxia caused a relatively high percentage increase in the low Se rats, the resulting absolute GSHPX activity was only 34 to 70% of that of unexposed high selenium rats. The results indicate that both selenium and sulfur-containing amino acids contribute to antioxidant defense. However, although the stress of hyperoxic exposure produces an increase in glutathione peroxidase activity, the absolute lung GSHPX activity is better correlated with tolerance than with adaptation to hyperoxia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6876743

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  7 in total

1.  Comparison of glutathione peroxidase 1 and peroxiredoxin 6 in protection against oxidative stress in the mouse lung.

Authors:  Geng Liu; Sheldon I Feinstein; Yan Wang; Chandra Dodia; Donald Fisher; Kevin Yu; Ye-Shih Ho; Aron B Fisher
Journal:  Free Radic Biol Med       Date:  2010-07-11       Impact factor: 7.376

2.  Pulmonary effects of short term selenium deficiency.

Authors:  D B Coursin; H P Cihla
Journal:  Thorax       Date:  1996-05       Impact factor: 9.139

3.  Tissue selenium accretion in premature and full-term human infants and children.

Authors:  P A Bayliss; B E Buchanan; R G Hancock; S H Zlotkin
Journal:  Biol Trace Elem Res       Date:  1985-02       Impact factor: 3.738

4.  Glutathione redox cycle is an important defense system of endothelial cells against chronic hyperoxia.

Authors:  N Suttorp; S Kästle; H Neuhof
Journal:  Lung       Date:  1991       Impact factor: 2.584

5.  Enhanced expression of superoxide dismutase messenger RNA in viral myocarditis. An SH-dependent reduction of its expression and myocardial injury.

Authors:  H Suzuki; A Matsumori; Y Matoba; B S Kyu; A Tanaka; J Fujita; S Sasayama
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

6.  Beneficial effects of N-acetylcysteine and cysteine in stunned myocardium in perfused rat heart.

Authors:  L D Tang; J Z Sun; K Wu; C P Sun; Z M Tang
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

7.  Attenuation of oxidant-induced lung injury by 21-aminosteroids (lazaroids): correlation with the mRNA expression for E-selectin, P-selectin, ICAM-1, and VCAM-1.

Authors:  R L Griffin; R F Krzesicki; S F Fidler; C L Rosenbloom; J A Auchampach; A M Manning; J V Haas; S K Cammarata; J E Chin; I M Richards
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.